Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.170
+0.080 (3.83%)
At close: Jul 22, 2026, 4:00 PM EDT
2.170
0.00 (0.00%)
After-hours: Jul 22, 2026, 8:00 PM EDT
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $130.00K in the twelve months ending March 31, 2026. In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth.
Revenue (ttm)
$130.00K
Revenue Growth
+132.14%
P/S Ratio
250.34
Revenue / Employee
$8,125
Employees
16
Market Cap
32.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130.00K | 74.00K | 132.14% |
| Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
| Dec 31, 2023 | 3.15M | 3.12M | 9,173.53% |
| Dec 31, 2022 | 34.00K | -110.00K | -76.39% |
| Dec 31, 2021 | 144.00K | -217.00K | -60.11% |
| Dec 31, 2020 | 361.00K | -1.37M | -79.11% |
| Dec 31, 2019 | 1.73M | 332.00K | 23.78% |
| Dec 31, 2018 | 1.40M | -8.00K | -0.57% |
| Dec 31, 2017 | 1.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veru Inc. | 16.89M |
| Kyntra Bio | 7.44M |
| Aligos Therapeutics | 4.71M |
| ABVC BioPharma | 797.92K |
| VYNE Therapeutics | 454.00K |
SER News
- 4 hours ago - Serina Therapeutics appoints Trevi Therapeutics CCO Farrell Simon to board - TheFly
- 13 days ago - Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252 - TheFly
- 13 days ago - Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire
- 21 days ago - Serina Therapeutics initiated with a Buy at BTIG - TheFly
- 22 days ago - Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 Program - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Serina Therapeutics files to sell 16.45M shares of common stock for holders - TheFly
- 2 months ago - Serina Therapeutics Registration statement: Registration filing - Filings